Casuarina glauca branchlets’ extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies
Ulcerative colitis (UC) is an inflammatory bowel disease that is often resistant to current treatment options, leading to a need for alternative therapies. Herbal products have shown promise in managing various conditions, including UC. However, the potential of Casuarina glauca branchlets ethanolic...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-12-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1322181/full |
| _version_ | 1827576600354357248 |
|---|---|
| author | Maged E. Mohamed Azza M. El-Shafae Eman Fikry Samar S. Elbaramawi Mahmoud H. Elbatreek Nora Tawfeek |
| author_facet | Maged E. Mohamed Azza M. El-Shafae Eman Fikry Samar S. Elbaramawi Mahmoud H. Elbatreek Nora Tawfeek |
| author_sort | Maged E. Mohamed |
| collection | DOAJ |
| description | Ulcerative colitis (UC) is an inflammatory bowel disease that is often resistant to current treatment options, leading to a need for alternative therapies. Herbal products have shown promise in managing various conditions, including UC. However, the potential of Casuarina glauca branchlets ethanolic extract (CGBRE) in treating UC has not been explored. This study aimed to analyze the chemical composition of CGBRE and evaluate its efficacy in UC treatment through in silico and in vivo experiments. LC-ESI-MS/MS was used to identify 86 compounds in CGBRE, with 21 potential bioactive compounds determined through pharmacokinetic analysis. Network pharmacology analysis revealed 171 potential UC targets for the bioactive compounds, including EGFR, LRRK2, and HSP90 as top targets, which were found to bind to key CGBRE compounds through molecular docking. Molecular docking findings suggested that CGBRE may be effective in the prevention or treatment of ulcerative colitis mediated by these proteins, where key CGBRE compounds exhibited good binding affinities through formation of numerous interactions. In vivo studies in rats with acetic acid-induced UC demonstrated that oral administration of 300 mg/kg CGBRE for 6 days reduced UC symptoms and colonic expression of EGFR, LRRK2, and HSP90. These findings supported the therapeutic potential of CGBRE in UC and suggested the need for further preclinical and clinical investigation. |
| first_indexed | 2024-03-08T21:14:45Z |
| format | Article |
| id | doaj.art-e1bbd7ecf21b411684b61fe394d9f2f2 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-03-08T21:14:45Z |
| publishDate | 2023-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-e1bbd7ecf21b411684b61fe394d9f2f22023-12-22T04:13:35ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-12-011410.3389/fphar.2023.13221811322181Casuarina glauca branchlets’ extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studiesMaged E. Mohamed0Azza M. El-Shafae1Eman Fikry2Samar S. Elbaramawi3Mahmoud H. Elbatreek4Nora Tawfeek5Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa, Saudi ArabiaDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig, EgyptDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig, EgyptDepartment of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig, EgyptDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig, EgyptDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig, EgyptUlcerative colitis (UC) is an inflammatory bowel disease that is often resistant to current treatment options, leading to a need for alternative therapies. Herbal products have shown promise in managing various conditions, including UC. However, the potential of Casuarina glauca branchlets ethanolic extract (CGBRE) in treating UC has not been explored. This study aimed to analyze the chemical composition of CGBRE and evaluate its efficacy in UC treatment through in silico and in vivo experiments. LC-ESI-MS/MS was used to identify 86 compounds in CGBRE, with 21 potential bioactive compounds determined through pharmacokinetic analysis. Network pharmacology analysis revealed 171 potential UC targets for the bioactive compounds, including EGFR, LRRK2, and HSP90 as top targets, which were found to bind to key CGBRE compounds through molecular docking. Molecular docking findings suggested that CGBRE may be effective in the prevention or treatment of ulcerative colitis mediated by these proteins, where key CGBRE compounds exhibited good binding affinities through formation of numerous interactions. In vivo studies in rats with acetic acid-induced UC demonstrated that oral administration of 300 mg/kg CGBRE for 6 days reduced UC symptoms and colonic expression of EGFR, LRRK2, and HSP90. These findings supported the therapeutic potential of CGBRE in UC and suggested the need for further preclinical and clinical investigation.https://www.frontiersin.org/articles/10.3389/fphar.2023.1322181/fullCasuarina glaucaulcerative colitisnetwork pharmacologydockingLRRK2EGFR |
| spellingShingle | Maged E. Mohamed Azza M. El-Shafae Eman Fikry Samar S. Elbaramawi Mahmoud H. Elbatreek Nora Tawfeek Casuarina glauca branchlets’ extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies Frontiers in Pharmacology Casuarina glauca ulcerative colitis network pharmacology docking LRRK2 EGFR |
| title | Casuarina glauca branchlets’ extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies |
| title_full | Casuarina glauca branchlets’ extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies |
| title_fullStr | Casuarina glauca branchlets’ extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies |
| title_full_unstemmed | Casuarina glauca branchlets’ extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies |
| title_short | Casuarina glauca branchlets’ extract as a potential treatment for ulcerative colitis: chemical composition, in silico and in vivo studies |
| title_sort | casuarina glauca branchlets extract as a potential treatment for ulcerative colitis chemical composition in silico and in vivo studies |
| topic | Casuarina glauca ulcerative colitis network pharmacology docking LRRK2 EGFR |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2023.1322181/full |
| work_keys_str_mv | AT magedemohamed casuarinaglaucabranchletsextractasapotentialtreatmentforulcerativecolitischemicalcompositioninsilicoandinvivostudies AT azzamelshafae casuarinaglaucabranchletsextractasapotentialtreatmentforulcerativecolitischemicalcompositioninsilicoandinvivostudies AT emanfikry casuarinaglaucabranchletsextractasapotentialtreatmentforulcerativecolitischemicalcompositioninsilicoandinvivostudies AT samarselbaramawi casuarinaglaucabranchletsextractasapotentialtreatmentforulcerativecolitischemicalcompositioninsilicoandinvivostudies AT mahmoudhelbatreek casuarinaglaucabranchletsextractasapotentialtreatmentforulcerativecolitischemicalcompositioninsilicoandinvivostudies AT noratawfeek casuarinaglaucabranchletsextractasapotentialtreatmentforulcerativecolitischemicalcompositioninsilicoandinvivostudies |